RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)

被引：0

作者：

Rudin, C. M. ^{[1
]}

Dowlati, A. ^{[2
]}

Chen, Y. ^{[3
]}

Navarro Mendivil, A. F. ^{[4
,5
]}

Yang, J. C-H. ^{[6
]}

Stojanovic, G. ^{[7
]}

Rich, P. ^{[8
]}

Andric, Z. G. ^{[9
]}

Wu, Y-L. ^{[10
]}

Chen, H. ^{[11
]}

Zhang, L. ^{[11
]}

Yeung, S. ^{[11
]}

Benzaghou, F. M. ^{[12
]}

Paz-Ares, L. ^{[13
]}

Bunn, P. A. ^{[14
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Druckenmiller Ctr Lung Canc Res, New York, NY USA

[2] Univ Hosp Seidman Canc Ctr, Oncol Dept, Cleveland, OH USA

[3] Canc & Hematol Ctr Western Michigan, Med Oncol Dept, Grand Rapids, MI USA

[4] Hosp Univ Vall Hebron, Barcelona, Spain

[5] Vall Hebron Inst Oncol VHIO, Barcelona, Spain

[6] NTUCC Natl Taiwan Univ Canc Ctr, Med Oncol Dept, Taipei, Taiwan

[7] Inst Pulm Dis Vojvodina, Clin Thorac Oncol, Sremska Kamenica, Serbia

[8] Southeastern Reg Med Ctr, Lumberton, NC USA

[9] Univ Clin Hosp Ctr Bezanijska Kosa, Med Oncol Dept, Belgrade, Serbia

[10] Guangdong Prov Peoples Hosp, Lung Canc Inst, Guangzhou, Peoples R China

[11] IPSEN Biosci Inc, Res & Dev Dept, Cambridge, MA USA

[12] IPSEN Biosci Inc, Oncol Dev Dept, Cambridge, MA USA

[13] Hosp Univ 12 Octubre, Med Oncol Dept, Edificio Maternidad 2 Planta, Madrid, Spain

[14] Univ Colorado Denver, Denver, CO USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

161O

引用

页码：S129 / S130

页数：2